The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and design

A (Sonia) Buist, William M. Vollmer, Sean D. Sullivan, Kevin B. Weiss, Todd A. Lee, Ana M B Menezes, Robert O. Crapo, Robert L. Jensen, Peter G J Burney

Research output: Contribution to journalArticle

207 Citations (Scopus)

Abstract

Quantifying COPD prevalence worldwide is needed to document COPD's effect on disability, health care costs, and impaired quality of life and to inform governments and health planners. As an adjunct to data obtained from population-based studies, and for countries where a fully powered prevalence survey cannot be done, modeling of COPD prevalence and its economic burdens can help estimate potential health care needs and costs. For comparability, standardized methods for prevalence surveys are needed that can be used in countries at all levels of economic development. The Burden of Obstructive Lung Disease (BOLD) Initiative has developed a set of methods for estimating COPD prevalence and a model for assessing its economic impact, and piloted these methods in China and Turkey. The methods were revised to reflect the findings in the pilot studies, and BOLD is now making the standardized methods available worldwide. The BOLD Operations Center provides training, materials, quality control, and data analysis. BOLD emphasizes data quality control at every stage of the process. Data from paper forms completed in the field are entered electronically to a specially designed secure Web platform. Pre- and post-bronchodilator spirometry testing is done on all participants, and all spirometry data are reviewed for quality. Questionnaires are used to obtain information about respiratory symptoms, health status, exposure to risk factors, and economic data about the burden of COPD. BOLD's standardized methods will provide a uniform way to compare COPD burden within and between countries, and where differences are found, to explore explanations for these differences.

Original languageEnglish (US)
Pages (from-to)277-283
Number of pages7
JournalCOPD: Journal of Chronic Obstructive Pulmonary Disease
Volume2
Issue number2
DOIs
StatePublished - 2005

Fingerprint

Obstructive Lung Diseases
Chronic Obstructive Pulmonary Disease
Bronchodilator Agents
Spirometry
Economics
Quality Control
Health Care Costs
Economic Development
Turkey
Health Status
China
Quality of Life
Health
Population
Surveys and Questionnaires

Keywords

  • Chronic obstructive pulmonary disease
  • Economic
  • Health care costs
  • Models
  • Prevalence
  • Statistical

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Buist, A. S., Vollmer, W. M., Sullivan, S. D., Weiss, K. B., Lee, T. A., Menezes, A. M. B., ... Burney, P. G. J. (2005). The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and design. COPD: Journal of Chronic Obstructive Pulmonary Disease, 2(2), 277-283. https://doi.org/10.1081/COPD-200057610

The Burden of Obstructive Lung Disease Initiative (BOLD) : Rationale and design. / Buist, A (Sonia); Vollmer, William M.; Sullivan, Sean D.; Weiss, Kevin B.; Lee, Todd A.; Menezes, Ana M B; Crapo, Robert O.; Jensen, Robert L.; Burney, Peter G J.

In: COPD: Journal of Chronic Obstructive Pulmonary Disease, Vol. 2, No. 2, 2005, p. 277-283.

Research output: Contribution to journalArticle

Buist, AS, Vollmer, WM, Sullivan, SD, Weiss, KB, Lee, TA, Menezes, AMB, Crapo, RO, Jensen, RL & Burney, PGJ 2005, 'The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and design', COPD: Journal of Chronic Obstructive Pulmonary Disease, vol. 2, no. 2, pp. 277-283. https://doi.org/10.1081/COPD-200057610
Buist, A (Sonia) ; Vollmer, William M. ; Sullivan, Sean D. ; Weiss, Kevin B. ; Lee, Todd A. ; Menezes, Ana M B ; Crapo, Robert O. ; Jensen, Robert L. ; Burney, Peter G J. / The Burden of Obstructive Lung Disease Initiative (BOLD) : Rationale and design. In: COPD: Journal of Chronic Obstructive Pulmonary Disease. 2005 ; Vol. 2, No. 2. pp. 277-283.
@article{e94f960bf1d44786833c8f0df120c3ef,
title = "The Burden of Obstructive Lung Disease Initiative (BOLD): Rationale and design",
abstract = "Quantifying COPD prevalence worldwide is needed to document COPD's effect on disability, health care costs, and impaired quality of life and to inform governments and health planners. As an adjunct to data obtained from population-based studies, and for countries where a fully powered prevalence survey cannot be done, modeling of COPD prevalence and its economic burdens can help estimate potential health care needs and costs. For comparability, standardized methods for prevalence surveys are needed that can be used in countries at all levels of economic development. The Burden of Obstructive Lung Disease (BOLD) Initiative has developed a set of methods for estimating COPD prevalence and a model for assessing its economic impact, and piloted these methods in China and Turkey. The methods were revised to reflect the findings in the pilot studies, and BOLD is now making the standardized methods available worldwide. The BOLD Operations Center provides training, materials, quality control, and data analysis. BOLD emphasizes data quality control at every stage of the process. Data from paper forms completed in the field are entered electronically to a specially designed secure Web platform. Pre- and post-bronchodilator spirometry testing is done on all participants, and all spirometry data are reviewed for quality. Questionnaires are used to obtain information about respiratory symptoms, health status, exposure to risk factors, and economic data about the burden of COPD. BOLD's standardized methods will provide a uniform way to compare COPD burden within and between countries, and where differences are found, to explore explanations for these differences.",
keywords = "Chronic obstructive pulmonary disease, Economic, Health care costs, Models, Prevalence, Statistical",
author = "Buist, {A (Sonia)} and Vollmer, {William M.} and Sullivan, {Sean D.} and Weiss, {Kevin B.} and Lee, {Todd A.} and Menezes, {Ana M B} and Crapo, {Robert O.} and Jensen, {Robert L.} and Burney, {Peter G J}",
year = "2005",
doi = "10.1081/COPD-200057610",
language = "English (US)",
volume = "2",
pages = "277--283",
journal = "COPD: Journal of Chronic Obstructive Pulmonary Disease",
issn = "1541-2555",
publisher = "Informa Healthcare",
number = "2",

}

TY - JOUR

T1 - The Burden of Obstructive Lung Disease Initiative (BOLD)

T2 - Rationale and design

AU - Buist, A (Sonia)

AU - Vollmer, William M.

AU - Sullivan, Sean D.

AU - Weiss, Kevin B.

AU - Lee, Todd A.

AU - Menezes, Ana M B

AU - Crapo, Robert O.

AU - Jensen, Robert L.

AU - Burney, Peter G J

PY - 2005

Y1 - 2005

N2 - Quantifying COPD prevalence worldwide is needed to document COPD's effect on disability, health care costs, and impaired quality of life and to inform governments and health planners. As an adjunct to data obtained from population-based studies, and for countries where a fully powered prevalence survey cannot be done, modeling of COPD prevalence and its economic burdens can help estimate potential health care needs and costs. For comparability, standardized methods for prevalence surveys are needed that can be used in countries at all levels of economic development. The Burden of Obstructive Lung Disease (BOLD) Initiative has developed a set of methods for estimating COPD prevalence and a model for assessing its economic impact, and piloted these methods in China and Turkey. The methods were revised to reflect the findings in the pilot studies, and BOLD is now making the standardized methods available worldwide. The BOLD Operations Center provides training, materials, quality control, and data analysis. BOLD emphasizes data quality control at every stage of the process. Data from paper forms completed in the field are entered electronically to a specially designed secure Web platform. Pre- and post-bronchodilator spirometry testing is done on all participants, and all spirometry data are reviewed for quality. Questionnaires are used to obtain information about respiratory symptoms, health status, exposure to risk factors, and economic data about the burden of COPD. BOLD's standardized methods will provide a uniform way to compare COPD burden within and between countries, and where differences are found, to explore explanations for these differences.

AB - Quantifying COPD prevalence worldwide is needed to document COPD's effect on disability, health care costs, and impaired quality of life and to inform governments and health planners. As an adjunct to data obtained from population-based studies, and for countries where a fully powered prevalence survey cannot be done, modeling of COPD prevalence and its economic burdens can help estimate potential health care needs and costs. For comparability, standardized methods for prevalence surveys are needed that can be used in countries at all levels of economic development. The Burden of Obstructive Lung Disease (BOLD) Initiative has developed a set of methods for estimating COPD prevalence and a model for assessing its economic impact, and piloted these methods in China and Turkey. The methods were revised to reflect the findings in the pilot studies, and BOLD is now making the standardized methods available worldwide. The BOLD Operations Center provides training, materials, quality control, and data analysis. BOLD emphasizes data quality control at every stage of the process. Data from paper forms completed in the field are entered electronically to a specially designed secure Web platform. Pre- and post-bronchodilator spirometry testing is done on all participants, and all spirometry data are reviewed for quality. Questionnaires are used to obtain information about respiratory symptoms, health status, exposure to risk factors, and economic data about the burden of COPD. BOLD's standardized methods will provide a uniform way to compare COPD burden within and between countries, and where differences are found, to explore explanations for these differences.

KW - Chronic obstructive pulmonary disease

KW - Economic

KW - Health care costs

KW - Models

KW - Prevalence

KW - Statistical

UR - http://www.scopus.com/inward/record.url?scp=22244441438&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=22244441438&partnerID=8YFLogxK

U2 - 10.1081/COPD-200057610

DO - 10.1081/COPD-200057610

M3 - Article

C2 - 17136954

AN - SCOPUS:22244441438

VL - 2

SP - 277

EP - 283

JO - COPD: Journal of Chronic Obstructive Pulmonary Disease

JF - COPD: Journal of Chronic Obstructive Pulmonary Disease

SN - 1541-2555

IS - 2

ER -